A Study to Evaluate the Efficacy and Safety of CBL-514 Compared to Placebo in Participants With Dercum ' s Disease Lipomas

Conditions: Dercum ' s Disease Interventions: Drug: CBL-514 injection; Drug: 0.9% Sodium chloride Sponsors: Caliway Biopharmaceuticals Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials